Delayed Serotonin Syndrome and Non-cardiogenic Pulmonary Edema Following Bupropion Overdose in a Seven-Year-Old Female: A Case Report and Review of Literature
- PMID: 38650797
- PMCID: PMC11033971
- DOI: 10.7759/cureus.56767
Delayed Serotonin Syndrome and Non-cardiogenic Pulmonary Edema Following Bupropion Overdose in a Seven-Year-Old Female: A Case Report and Review of Literature
Abstract
Bupropion is an atypical antidepressant prescribed for depression and attention-deficit/hyperactivity disorder and to aid in smoking cessation. Bupropion overdose management is largely aimed toward common sequelae, including seizures, tachycardia, and QTc prolongation. In this case report, we identify a rare event of pediatric bupropion overdose with aforementioned common sequela and atypical features, including a delayed presentation of serotonin syndrome and non-cardiogenic pulmonary edema. This case follows a seven-year-old Caucasian female with autism spectrum disorder (ASD) who presented in status epilepticus following an accidental bupropion overdose and required multiple anti-seizure medications, endotracheal intubation, and admission to the pediatric intensive care unit (PICU). The patient's condition improved, and she was extubated 25 hours after admission and transitioned to high-flow nasal cannula therapy. On day 3 of admission, she became febrile and developed dyspnea with decreased breath sounds and intercostal retractions, tachycardia, a rigid abdomen and extremities with sporadic tremors, pulmonary edema, and a prolonged QTc interval. Targeted therapies were initiated, and following treatment, our patient showed remarkable improvement in the subsequent 24 hours and was discharged home five days after the initial presentation. This case identifies a delayed presentation of uncommon and serious complications of bupropion overdose, including pulmonary edema and serotonin syndrome, in a pediatric patient. Prompt investigation and identification of bupropion toxicity can help practitioners mitigate further complications during admission and reduce morbidity and mortality.
Keywords: bupropion overdose; non-cardiogenic pulmonary edema; prolonged qtc interval; serotonin toxicity; status epilepticus (se).
Copyright © 2024, Craft et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures







Similar articles
-
Atypical Findings in Massive Bupropion Overdose: A Case Report and Discussion of Psychopharmacologic Issues.J Psychiatr Pract. 2016 Sep;22(5):405-9. doi: 10.1097/PRA.0000000000000179. J Psychiatr Pract. 2016. PMID: 27648505
-
Two Cases of Serotonin Syndrome After Bupropion Overdose Treated With Cyproheptadine.J Emerg Med. 2021 Apr;60(4):e67-e71. doi: 10.1016/j.jemermed.2020.10.039. Epub 2020 Dec 8. J Emerg Med. 2021. PMID: 33308914
-
A 19-Year-Old Woman with a History of Depression and Fatal Cardiorespiratory Failure Following an Overdose of Prescribed Bupropion.Am J Case Rep. 2021 Jul 26;22:e931783. doi: 10.12659/AJCR.931783. Am J Case Rep. 2021. PMID: 34305134 Free PMC article.
-
Factors associated with seizure development after bupropion overdose: a review of the toxicology investigators consortium.Clin Toxicol (Phila). 2021 Dec;59(12):1234-1238. doi: 10.1080/15563650.2021.1913180. Epub 2021 Apr 21. Clin Toxicol (Phila). 2021. PMID: 33878992 Review.
-
Cardiotoxicity following bupropion overdose.Ann Pharmacother. 2002 Nov;36(11):1791-5. doi: 10.1345/aph.1C045. Ann Pharmacother. 2002. PMID: 12398578 Review.
References
-
- Labbate LA, Fava M, Rosenbaum JF, Arana GW. Handbook of Psychiatric Drug Therapy. Philadelphia (PA): Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010. Drugs for the treatment of depression; p. 54.
-
- Bupropion: pharmacology and therapeutic applications. Foley KF, DeSanty KP, Kast RE. Expert Rev Neurother. 2006;6:1249–1265. - PubMed
-
- How should primary care doctors select which antidepressants to administer? Gartlehner G, Thaler K, Hill S, Hansen RA. Curr Psychiatry Rep. 2012;14:360–369. - PubMed
-
- Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Jefferson JW, Pradko JF, Muir KT. Clin Ther. 2005;27:1685–1695. - PubMed
-
- Serotonin syndrome. Presentation of 2 cases and review of the literature. Mason PJ, Morris VA, Balcezak TJ. Medicine (Baltimore) 2000;79:201–209. - PubMed
Publication types
LinkOut - more resources
Full Text Sources